Skip to main content

Tebentafusp Disease Interactions

There are 2 disease interactions with tebentafusp.

Moderate

Tebentafusp (applies to tebentafusp) liver dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Tebentafusp has not been studied in patients with moderate to severe liver dysfunction; caution is recommended in these patients. Because increases in ALT or AST have been observed in patients treated with tebentafusp, ALT, AST, and total blood bilirubin should be monitored before starting and during treatment with tebentafusp.

References

  1. (2022) "Product Information. Kimmtrak (tebentafusp)." Immunocore LLC
Moderate

Tebentafusp (applies to tebentafusp) renal dysfunction

Moderate Potential Hazard, Moderate plausibility.

Tebentafusp has not been studied in patients with severe renal dysfunction (CrCl less than 30 mL/min); caution is recommended in these patients.

References

  1. (2022) "Product Information. Kimmtrak (tebentafusp)." Immunocore LLC

Tebentafusp drug interactions

There are 291 drug interactions with tebentafusp.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.